Sam Brusco, Associate Editor02.16.22
Raumedic Inc., a Mills River, N.C.-based provder of medical-grade thermoplastic polymers and silicones, has appointed Brian Hutchison as its new president and CEO. He took over the position on February 8 from Stefan Seuferling, who will remain Board Chairman and CEO of Raumedic AG.
“We are really happy that we could attract an experienced and successful executive like Brian Hutchison to Raumedic,” Seuferling told the press. “The U.S. market is filled with potential for Raumedic. We really believe that we will be able to continue expanding our business activities there now that we have brought Brian Hutchison on board.”
Hutchison has over 30 years of experience in medical devices and biotechnology. He previously held high-ranking positions at Stryker, RTI Surgical, and Catalyst OrthoScience.
He plans to focus on expanding Raumedic Inc.’s business units, focusing explicitly on the pharma market in addition to medical technology.
“Pharma fluid handling, cell therapy, and drug delivery are just three areas where I see tremendous growth potential,” Hutchison said.
“We are really happy that we could attract an experienced and successful executive like Brian Hutchison to Raumedic,” Seuferling told the press. “The U.S. market is filled with potential for Raumedic. We really believe that we will be able to continue expanding our business activities there now that we have brought Brian Hutchison on board.”
Hutchison has over 30 years of experience in medical devices and biotechnology. He previously held high-ranking positions at Stryker, RTI Surgical, and Catalyst OrthoScience.
He plans to focus on expanding Raumedic Inc.’s business units, focusing explicitly on the pharma market in addition to medical technology.
“Pharma fluid handling, cell therapy, and drug delivery are just three areas where I see tremendous growth potential,” Hutchison said.